Danny A. J. P. van de Sande
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danny A. J. P. van de Sande has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Hareld Marijn Clemens Kemps
Department of Industrial Design, Eindhoven University of Technology, Eindhoven, The Netherlands
12 shared publications - Lonneke Fruytier
Department of Cardiology, Maxima Medical Center, Veldhoven, the Netherlands
6 shared publications Jan Hoogsteen
Department of Cardiology, Maxima Medical Center, Veldhoven, the Netherlands
4 shared publications- Aarnout Brombacher
Jheronimus Academy of Data Science, Eindhoven University of Technology, ‘s-Hertogenbosch, The Netherlands
3 shared publications - Irina Bianca Șerban
Eindhoven University of Technology
3 shared publications - Sara Colombo
Knowledge and Intelligence Design, Delft University of Technology, Delft, Netherlands
3 shared publications
Latest Publications
- Open Access
- 16 October 2025
- Published by Association for Computing Machinery (ACM) in Proceedings of the ACM on Human-Computer Interaction
- Vol. 9 (7) , 1-32
Less Supervising, More Caring: Design Recommendations for Informal Caregivers' Co-Participation in Cardiac Telerehabilitation
Informal caregivers' engagement with patient data is becoming increasingly central to CSCW and HCI research on health management. Cardiac telerehabilitation (CTR) technologies generate lifestyle and well-being data that support patients and their families in recovery management, yet informal caregivers' roles in CTR remain underexplored. Recreational athletes in rehabilitation are an especially under-researched group, despite their and their support system's unique needs. Focusing on caregivers of recreational athletes, we conducted interviews with ten participants and used six visual scenarios of a dyadic CTR system to explore their perspectives on data and information co-participation. Caregivers reported that co-participation could strengthen dyadic coping and management but emphasized the need to balance important trade-offs. We provide design recommendations for dyadic CTR systems that balance care needs and preferences, promoting caregiver involvement in a supportive, non-supervisory role. We contribute to CSCW research by proposing a conceptual shift in technology-mediated rehabilitation care: positioning caregiver-inclusive CTR systems as negotiation tools that support boundary work and balance competing care values.
- 16 October 2025
- Published by Association for Computing Machinery (ACM) in Proceedings of the ACM on Human-Computer Interaction
- Vol. 9 (7) , 1-32
Open AccessLess Supervising, More Caring: Design Recommendations for Informal Caregivers' Co-Participation in Cardiac Telerehabilitation
Informal caregivers' engagement with patient data is becoming increasingly central to CSCW and HCI research on health management. Cardiac telerehabilitation (CTR) technologies generate lifestyle and well-being data that support patients and their families in recovery management, yet informal caregivers' roles in CTR remain underexplored. Recreational athletes in rehabilitation are an especially under-researched group, despite their and their support system's unique needs. Focusing on caregivers of recreational athletes, we conducted interviews with ten participants and used six visual scenarios of a dyadic CTR system to explore their perspectives on data and information co-participation. Caregivers reported that co-participation could strengthen dyadic coping and management but emphasized the need to balance important trade-offs. We provide design recommendations for dyadic CTR systems that balance care needs and preferences, promoting caregiver involvement in a supportive, non-supervisory role. We contribute to CSCW research by proposing a conceptual shift in technology-mediated rehabilitation care: positioning caregiver-inclusive CTR systems as negotiation tools that support boundary work and balance competing care values.
- Open Access
- 30 September 2025
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 9, e69343
Analysis of a Medically Certified, Wrist-Worn Sensor for the Assessment of Heart Rate and Energy Expenditure During Daily Activities in Patients With Chronic Heart Failure or Coronary Artery Disease and Recreational Athletes: Validation Study
Background: Exercise capacity and lifestyle have proven to be important prognostic factors for cardiovascular patients. Both can be ameliorated through different preventive interventions. Cardiac rehabilitation and remote patient monitoring have been proven to reduce cardiac events and cardiovascular mortality. One of the most important goals of cardiac rehabilitation and remote patient monitoring is improving physical fitness and monitoring of cardiovascular parameters, which could predict cardiac deterioration. In order to monitor cardiac patients successfully, reliable and nonobtrusive devices to assess physical activity and cardiovascular parameters need to be available. Objective: This validation study aims to determine the accuracy of the Philips Health Band (PHB), a noninvasive, wrist-worn, medically certified device, for the assessment of heart rate (HR) and energy expenditure (EE) in patients with chronic cardiovascular diseases and recreational athletes (RAs). Methods: The assessment of HR and EE by the PHB was compared with indirect calorimetry (Oxycon Mobile [OM; CareFusion GmbH]) during an activity protocol consisting of daily activities. Three groups were assessed: patients with heart failure with reduced ejection fraction (HFrEF), patients with stable coronary artery disease (CAD) with preserved left ventricular ejection fraction, and RAs. Results: A total of 57 patients were included: 19 with CAD, 19 with HFrEF, and 19 RAs. HR assessment in the HFrEF and CAD groups was significantly underestimated over the entire protocol by the PHB as compared to the OM, with poor and fair reliability, respectively. No significant difference in HR was found between the PHB and OM over the entire protocol for the RA group, with good reliability (HFrEF: mean difference 3.0; P <.001; intraclass correlation coefficient [ICC] 0.36; CAD: mean difference 2.7; P <.001; ICC 0.55; RA: mean difference 0.8; ICC 0.60). Assessment of EE showed an underestimation over the entire protocol for the RA and CAD group, with poor and fair reliability, respectively. The HFrEF group showed no significant difference in EE assessment over the entire protocol, with poor reliability (HFrEF: mean difference 0.09; ICC 0.32; CAD: mean difference 0.29; P <.001; ICC 0.46; RA: mean difference 0.79; P <.001; ICC 0.26). The responsiveness to detect within-patient changes in activity intensity of the PHB was moderate for the HFrEF and CAD groups and acceptable for the RA group. Conclusions: HR and EE assessment of a medically certified noninvasive sensor using a photoplethysmogram and accelerometer showed poor accuracy and moderate responsiveness during an activity protocol reflecting daily living activities in patients with stable CAD and chronic HFrEF. Accuracy of HR in RAs was good and the responsiveness for both HR and EE was acceptable. This research confirms previous research and stresses the need for better patient-specific algorithms in noninvasive sensors, taking cardiovascular pathology and medication usage into account, for assessing HR and EE prior to their implemention in patient care.
- 30 September 2025
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 9, e69343
Open AccessAnalysis of a Medically Certified, Wrist-Worn Sensor for the Assessment of Heart Rate and Energy Expenditure During Daily Activities in Patients With Chronic Heart Failure or Coronary Artery Disease and Recreational Athletes: Validation Study
Background: Exercise capacity and lifestyle have proven to be important prognostic factors for cardiovascular patients. Both can be ameliorated through different preventive interventions. Cardiac rehabilitation and remote patient monitoring have been proven to reduce cardiac events and cardiovascular mortality. One of the most important goals of cardiac rehabilitation and remote patient monitoring is improving physical fitness and monitoring of cardiovascular parameters, which could predict cardiac deterioration. In order to monitor cardiac patients successfully, reliable and nonobtrusive devices to assess physical activity and cardiovascular parameters need to be available. Objective: This validation study aims to determine the accuracy of the Philips Health Band (PHB), a noninvasive, wrist-worn, medically certified device, for the assessment of heart rate (HR) and energy expenditure (EE) in patients with chronic cardiovascular diseases and recreational athletes (RAs). Methods: The assessment of HR and EE by the PHB was compared with indirect calorimetry (Oxycon Mobile [OM; CareFusion GmbH]) during an activity protocol consisting of daily activities. Three groups were assessed: patients with heart failure with reduced ejection fraction (HFrEF), patients with stable coronary artery disease (CAD) with preserved left ventricular ejection fraction, and RAs. Results: A total of 57 patients were included: 19 with CAD, 19 with HFrEF, and 19 RAs. HR assessment in the HFrEF and CAD groups was significantly underestimated over the entire protocol by the PHB as compared to the OM, with poor and fair reliability, respectively. No significant difference in HR was found between the PHB and OM over the entire protocol for the RA group, with good reliability (HFrEF: mean difference 3.0; P <.001; intraclass correlation coefficient [ICC] 0.36; CAD: mean difference 2.7; P <.001; ICC 0.55; RA: mean difference 0.8; ICC 0.60). Assessment of EE showed an underestimation over the entire protocol for the RA and CAD group, with poor and fair reliability, respectively. The HFrEF group showed no significant difference in EE assessment over the entire protocol, with poor reliability (HFrEF: mean difference 0.09; ICC 0.32; CAD: mean difference 0.29; P <.001; ICC 0.46; RA: mean difference 0.79; P <.001; ICC 0.26). The responsiveness to detect within-patient changes in activity intensity of the PHB was moderate for the HFrEF and CAD groups and acceptable for the RA group. Conclusions: HR and EE assessment of a medically certified noninvasive sensor using a photoplethysmogram and accelerometer showed poor accuracy and moderate responsiveness during an activity protocol reflecting daily living activities in patients with stable CAD and chronic HFrEF. Accuracy of HR in RAs was good and the responsiveness for both HR and EE was acceptable. This research confirms previous research and stresses the need for better patient-specific algorithms in noninvasive sensors, taking cardiovascular pathology and medication usage into account, for assessing HR and EE prior to their implemention in patient care.
- Open Access
- 2 June 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (7) , 1199-1207
Extreme phenotypes of the female athlete’s heart: a sports-specific cardiac magnetic resonance imaging study
Aims: Differentiating physiological exercise-induced cardiac remodelling (EICR) from pathology is challenging, especially in female athletes, where studies using state-of-the-art imaging techniques are lacking. We aimed to investigate extreme phenotypes of EICR in female elite athletes using magnetic resonance imaging (MRI). Methods and results: Cross-sectional, multicentre study in female elite athletes using contrast-enhanced cardiac MRI. Left and right ventricle (LV, RV) indices and LV mass (LVM)-to-LV end-diastolic volume (EDV) ratios were investigated, indexed by body surface area (BSA). Cardiac remodelling was determined comparing cardiac MRI metrics to female reference values, stratified by ESC sports classification (endurance, mixed, power/skill). In 173 female elite athletes (median age 25 years, median 18 h training/week, 97% Caucasian), mean LV EDV/BSA and LVM/BSA were 108 ± 13 mL/m2 and 50 ± 10 g/m2, with lower LVM/LV EDV ratios (0.5 ± 0.1) than the general population (0.7 ± 0.1 g/mL; P < 0.001). Most athletes (71%) had isolated LV EDV increases; LVM increases (18%) commonly coincided with LV EDV increases. Compared with the general population (45 ± 7 g/m2), only mixed (48 ± 9 g/m2; P = 0.021) and endurance athletes (53 ± 11 g/m2; P < 0.001) exhibited greater mean LVM with endurance athletes surpassing mixed athletes (P = 0.004). Mixed and endurance showed comparably greater median biventricular EDV compared with power/skill athletes [LV: 109 (103–119) and 111 (101–118) vs. 99 (92–105); RV: 110 (103–118) and 112 (105–124) vs. 101 (95–104) mL/m2; P < 0.001]. Maximum wall thickness > 11 mm was rare (2%). Global T1 time was 968 ± 22 ms; extracellular volume was 25 ± 4%. Conclusion: Female elite athletes, particularly endurance-trained athletes, display EICR marked by increased ventricular volumes, without prominent increases in LVM or wall thickness. Trial Registration Number: NL9328
- 2 June 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (7) , 1199-1207
Open AccessExtreme phenotypes of the female athlete’s heart: a sports-specific cardiac magnetic resonance imaging study
Aims: Differentiating physiological exercise-induced cardiac remodelling (EICR) from pathology is challenging, especially in female athletes, where studies using state-of-the-art imaging techniques are lacking. We aimed to investigate extreme phenotypes of EICR in female elite athletes using magnetic resonance imaging (MRI). Methods and results: Cross-sectional, multicentre study in female elite athletes using contrast-enhanced cardiac MRI. Left and right ventricle (LV, RV) indices and LV mass (LVM)-to-LV end-diastolic volume (EDV) ratios were investigated, indexed by body surface area (BSA). Cardiac remodelling was determined comparing cardiac MRI metrics to female reference values, stratified by ESC sports classification (endurance, mixed, power/skill). In 173 female elite athletes (median age 25 years, median 18 h training/week, 97% Caucasian), mean LV EDV/BSA and LVM/BSA were 108 ± 13 mL/m2 and 50 ± 10 g/m2, with lower LVM/LV EDV ratios (0.5 ± 0.1) than the general population (0.7 ± 0.1 g/mL; P < 0.001). Most athletes (71%) had isolated LV EDV increases; LVM increases (18%) commonly coincided with LV EDV increases. Compared with the general population (45 ± 7 g/m2), only mixed (48 ± 9 g/m2; P = 0.021) and endurance athletes (53 ± 11 g/m2; P < 0.001) exhibited greater mean LVM with endurance athletes surpassing mixed athletes (P = 0.004). Mixed and endurance showed comparably greater median biventricular EDV compared with power/skill athletes [LV: 109 (103–119) and 111 (101–118) vs. 99 (92–105); RV: 110 (103–118) and 112 (105–124) vs. 101 (95–104) mL/m2; P < 0.001]. Maximum wall thickness > 11 mm was rare (2%). Global T1 time was 968 ± 22 ms; extracellular volume was 25 ± 4%. Conclusion: Female elite athletes, particularly endurance-trained athletes, display EICR marked by increased ventricular volumes, without prominent increases in LVM or wall thickness. Trial Registration Number: NL9328
- Open Access
- 17 April 2025
- Published by JMIR Publications Inc. in JMIR Rehabilitation and Assistive Technologies
- Vol. 12 (1) , e62986
Design Requirements for Cardiac Telerehabilitation Technologies Supporting Athlete Values: Qualitative Interview Study
Background: Cardiac telerehabilitation (CTR) interventions can provide accessible and affordable remote rehabilitation services. However, as cardiac rehabilitation (CR) primarily targets inactive patients, little is known about the experiences with CR of highly active patients (ie, recreational athletes or, simply, athletes) with established coronary artery disease. Consequently, existing CTR interventions do not address the specific needs of the athletic subpopulation. Understanding the needs and values of athletes is crucial for designing meaningful CTR interventions that enhance user acceptance and engagement, thereby facilitating effective rehabilitation for this patient subgroup. Objective: This study aimed to inform the design of technologies that facilitate CTR for athletes. We intended to identify athletes’ values related to CR, including health and sports tracking, as well as high-level requirements for technologies that can facilitate the CTR of athletes according to the identified values. Methods: We used value-sensitive design with a human-centric design approach to elicit design requirements for CTR that can serve athletes with established coronary artery disease. To identify athletes’ values, we conducted 25 value-oriented semistructured interviews with 15 athletic patients and 10 health care professionals involved in CR programs. In a second phase, we conducted 6 card-sorting focus group sessions with 13 patients and 7 health care professionals to identify desired CTR features. Finally, we derived high-level CTR technology requirements connected to the athletes’ needs and values. Results: We defined 12 athlete values divided into 3 categories: body centric, care centric, and data and technology centric. We clustered findings from the card-sorting activity into CTR technology requirements, such as remotely monitored sport-specific training and training data representations next to clinical limitations, and paired them with corresponding values. Conclusions: Athletes have distinct values and health goals in CR compared to general populations targeted by CTR interventions. Designing patient-centric CTR interventions that address these needs is crucial to support optimal recovery, safe return to sports, and adherence to CTR technologies in the home environment.
- 17 April 2025
- Published by JMIR Publications Inc. in JMIR Rehabilitation and Assistive Technologies
- Vol. 12 (1) , e62986
Open AccessDesign Requirements for Cardiac Telerehabilitation Technologies Supporting Athlete Values: Qualitative Interview Study
Background: Cardiac telerehabilitation (CTR) interventions can provide accessible and affordable remote rehabilitation services. However, as cardiac rehabilitation (CR) primarily targets inactive patients, little is known about the experiences with CR of highly active patients (ie, recreational athletes or, simply, athletes) with established coronary artery disease. Consequently, existing CTR interventions do not address the specific needs of the athletic subpopulation. Understanding the needs and values of athletes is crucial for designing meaningful CTR interventions that enhance user acceptance and engagement, thereby facilitating effective rehabilitation for this patient subgroup. Objective: This study aimed to inform the design of technologies that facilitate CTR for athletes. We intended to identify athletes’ values related to CR, including health and sports tracking, as well as high-level requirements for technologies that can facilitate the CTR of athletes according to the identified values. Methods: We used value-sensitive design with a human-centric design approach to elicit design requirements for CTR that can serve athletes with established coronary artery disease. To identify athletes’ values, we conducted 25 value-oriented semistructured interviews with 15 athletic patients and 10 health care professionals involved in CR programs. In a second phase, we conducted 6 card-sorting focus group sessions with 13 patients and 7 health care professionals to identify desired CTR features. Finally, we derived high-level CTR technology requirements connected to the athletes’ needs and values. Results: We defined 12 athlete values divided into 3 categories: body centric, care centric, and data and technology centric. We clustered findings from the card-sorting activity into CTR technology requirements, such as remotely monitored sport-specific training and training data representations next to clinical limitations, and paired them with corresponding values. Conclusions: Athletes have distinct values and health goals in CR compared to general populations targeted by CTR interventions. Designing patient-centric CTR interventions that address these needs is crucial to support optimal recovery, safe return to sports, and adherence to CTR technologies in the home environment.
- Open Access
- 1 March 2025
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 19, 685-698
Exploring the Needs and Preferences of Athletes in Cardiac (Tele)Rehabilitation to Enhance Rehabilitation Outcome: A Qualitative Study
To define the user needs and preferences of the athletic population in cardiac (tele)rehabilitation (CTR). In this qualitative study, we included athletes with established coronary artery disease (CAD) who participated in a cardiac rehabilitation (CR) program and health care professionals involved in CR. All athletes engaged in sports for at least four hours per week. Fourteen male and one female athlete (mean age 63 ± 10.6 years) participated in CR after an acute coronary syndrome, percutaneous coronary intervention and/or coronary bypass surgery. The twelve healthcare professionals invited included cardiac nurse practitioners, cardiologists, sports physicians, physiotherapists, and a clinical psychologist. This study consists of four phases: a stakeholder identification session, twenty-five semi-structured individual interviews, six card-sorting focus groups and a data analysis phase with thematic analysis. User needs for athletes in CR encompass personalized exercise plans featuring clear and quantifiable exercise recommendations and limitations. Additionally, there is a need for monitoring health and exercise data; measuring progression and performance longitudinally; easy-to-use, and reliable healthcare information systems with accurate sensors and data; as well as clinical supervision and validation of information and data. Social support from both peers and family is also identified as a crucial need. The preferred technological features for a CTR system tailored for athletes include periodic digital consultations with clinicians, home-based training specific to one's sport, utilization of technology to monitor workouts, data sharing and remote feedback, personalized exercise recommendations and online educational materials. This research explored the user needs and preferences of athlete patients in CR. The findings indicated that enhancing CR for athletes necessitates a personalized and sport-specific methodology. The integration of various technological features within a CTR program can play a pivotal role in assisting athletes with CAD to maintain an active lifestyle and regain their previous athletic performance levels.
- 1 March 2025
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 19, 685-698
Open AccessExploring the Needs and Preferences of Athletes in Cardiac (Tele)Rehabilitation to Enhance Rehabilitation Outcome: A Qualitative Study
To define the user needs and preferences of the athletic population in cardiac (tele)rehabilitation (CTR). In this qualitative study, we included athletes with established coronary artery disease (CAD) who participated in a cardiac rehabilitation (CR) program and health care professionals involved in CR. All athletes engaged in sports for at least four hours per week. Fourteen male and one female athlete (mean age 63 ± 10.6 years) participated in CR after an acute coronary syndrome, percutaneous coronary intervention and/or coronary bypass surgery. The twelve healthcare professionals invited included cardiac nurse practitioners, cardiologists, sports physicians, physiotherapists, and a clinical psychologist. This study consists of four phases: a stakeholder identification session, twenty-five semi-structured individual interviews, six card-sorting focus groups and a data analysis phase with thematic analysis. User needs for athletes in CR encompass personalized exercise plans featuring clear and quantifiable exercise recommendations and limitations. Additionally, there is a need for monitoring health and exercise data; measuring progression and performance longitudinally; easy-to-use, and reliable healthcare information systems with accurate sensors and data; as well as clinical supervision and validation of information and data. Social support from both peers and family is also identified as a crucial need. The preferred technological features for a CTR system tailored for athletes include periodic digital consultations with clinicians, home-based training specific to one's sport, utilization of technology to monitor workouts, data sharing and remote feedback, personalized exercise recommendations and online educational materials. This research explored the user needs and preferences of athlete patients in CR. The findings indicated that enhancing CR for athletes necessitates a personalized and sport-specific methodology. The integration of various technological features within a CTR program can play a pivotal role in assisting athletes with CAD to maintain an active lifestyle and regain their previous athletic performance levels.
- 1 December 2024
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 17 (6) , e004561
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating MYBPC3 Founder Variant Carriers
BACKGROUND: MYBPC3 founder variants cause hypertrophic cardiomyopathy leading to heart failure and malignant ventricular arrhythmias. Exercise is typically regarded as a risk factor for disease expression although evidence is conflicting. Stratifying by type of exercise may discriminate low- from high-risk activities in these patients. Here, we evaluate the effects of exercise, stratified by high-static and high-dynamic components, on the risk of major cardiomyopathy-related events (MCEs) and cardiomyopathy penetrance among MYBPC3 founder variant carriers. METHODS: We interviewed 188 carriers (57.4% male; aged 43.0±15.0 years) on exercise participation since the age of 10 years. The exercise was quantified as the metabolic equivalent of task-h/wk before the presentation. MCE was defined as a composite of malignant ventricular arrhythmia (sustained ventricular tachycardia/fibrillation), heart failure (heart failure hospitalizations or transplantation), and septal reduction therapy. Static and dynamic exercises were defined per the Bethesda classification. Associations of exercise with MCE and cardiomyopathy penetrance were adjusted for sex and assessed using Cox regression. RESULTS: Overall, 43 (22.9%) subjects experienced MCE and 139 (73.9%) were diagnosed with cardiomyopathy. No association was found between overall physical activity and high-static activity with MCE ( P =0.587 overall; P =0.322 high static) or cardiomyopathy penetrance ( P =0.317 overall; P =0.623 high static). In contrast, high-dynamic activity was associated with malignant ventricular arrhythmia (dichotomized at the 75th percentile: adjusted hazard ratio, 3.26 [95% CI, 1.26–8.44]; P =0.015). CONCLUSIONS: Overall exercise participation does not generally increase the risk of adverse events among MYBPC3 founder variant carriers. Nonetheless, an increased risk of malignant ventricular arrhythmia was observed among those engaged in the highest quartile of high-dynamic sports, suggesting that high-level high-intensity exercise activities should be entertained with caution.
- 1 December 2024
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 17 (6) , e004561
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating MYBPC3 Founder Variant Carriers
BACKGROUND: MYBPC3 founder variants cause hypertrophic cardiomyopathy leading to heart failure and malignant ventricular arrhythmias. Exercise is typically regarded as a risk factor for disease expression although evidence is conflicting. Stratifying by type of exercise may discriminate low- from high-risk activities in these patients. Here, we evaluate the effects of exercise, stratified by high-static and high-dynamic components, on the risk of major cardiomyopathy-related events (MCEs) and cardiomyopathy penetrance among MYBPC3 founder variant carriers. METHODS: We interviewed 188 carriers (57.4% male; aged 43.0±15.0 years) on exercise participation since the age of 10 years. The exercise was quantified as the metabolic equivalent of task-h/wk before the presentation. MCE was defined as a composite of malignant ventricular arrhythmia (sustained ventricular tachycardia/fibrillation), heart failure (heart failure hospitalizations or transplantation), and septal reduction therapy. Static and dynamic exercises were defined per the Bethesda classification. Associations of exercise with MCE and cardiomyopathy penetrance were adjusted for sex and assessed using Cox regression. RESULTS: Overall, 43 (22.9%) subjects experienced MCE and 139 (73.9%) were diagnosed with cardiomyopathy. No association was found between overall physical activity and high-static activity with MCE ( P =0.587 overall; P =0.322 high static) or cardiomyopathy penetrance ( P =0.317 overall; P =0.623 high static). In contrast, high-dynamic activity was associated with malignant ventricular arrhythmia (dichotomized at the 75th percentile: adjusted hazard ratio, 3.26 [95% CI, 1.26–8.44]; P =0.015). CONCLUSIONS: Overall exercise participation does not generally increase the risk of adverse events among MYBPC3 founder variant carriers. Nonetheless, an increased risk of malignant ventricular arrhythmia was observed among those engaged in the highest quartile of high-dynamic sports, suggesting that high-level high-intensity exercise activities should be entertained with caution.
- Open Access
- 27 November 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Validation of a medically certified, wrist-worn sensor for the assessment of heart rate and energy expenditure during daily activities in patients with chronic heart failure, coronary artery disease and recreational athletes (Preprint)
BACKGROUND Exercise capacity and lifestyle have proven to be important prognostic factors for cardiovascular patients. Both can be ameliorated through different preventive interventions. Cardiac rehabilitation (CR) and remote patient monitoring (RPM) have proven to reduce cardiac events and cardiovascular mortality. One of the most important goals of CR and RPM is improving physical fitness and monitoring of cardiovascular parameters which could predict cardiac deterioration. In order to monitor cardiac patients successfully, reliable and non-obtrusive devices to assess physical activity (PA) and cardiovascular parameters need to be available. OBJECTIVE The aim of this validation study was to determine the accuracy of the Philips health band (PHB), a non-invasive, wrist-worn, medically certified device, for the assessment of heart rate (HR) and energy expenditure (EE) in chronic cardiovascular patients and recreational athletes. METHODS Assessment of HR and EE by the PHB was compared with indirect calorimetry (Oxycon Mobile (OM)) during an activity protocol, consisting of daily activities. Three groups were assessed: patients with heart failure with reduced ejection fraction (HFrEF), patients with stable coronary artery disease (CAD) with preserved left ventricular ejection fraction (LVEF) and recreational athletes (RA). RESULTS A total of 57 patients were included: 19 with CAD, 19 with HFrEF and 19 recreational athletes. HR assessment in the HFrEF and CAD group was significantly underestimated over the entire protocol by the PHB as compared to the OM, with poor and fair reliability respectively. No significant difference in HR was found between the PHB and OM over the entire protocol for the RA group, with a good reliability (HFrEF: mean difference 2.97, p<0.001, ICC 0.36; CAD: mean difference 2.65, p<0.001, ICC 0.55; RA: mean difference 0.78, ICC 0.60). Assessment of EE showed an underestimation over the entire protocol for the RA and CAD group, with poor and fair reliability respectively. The HFrEF group showed no significant difference in EE assessment over the entire protocol, with a poor reliability. (HFrEF: mean difference 0.09, ICC 0.32; CAD: mean difference 0.29, p<0.001, ICC 0.46; RA: mean difference 0.79, p<0.001, ICC 0.26). The responsiveness, to detect within patient changes in activity intensity, of the PHB was moderate for the HFrEF and CAD group, and acceptable for the RA group. CONCLUSIONS HR and EE assessment of a medically certified non-invasive sensor, using PPG and accelerometer, showed poor accuracy and moderate responsiveness during an activity protocol reflecting daily living activities in patients with stable CAD and chronic HFrEF. Accuracy of HR in recreational athletes was good and responsiveness for both HR and EE acceptable. This research confirms prior research and stresses the need for better patient specific algorithms in non-invasive sensors, taking cardiovascular pathology and medication usage into account, for assessing HR and EE, before implementing them in patient care.
- 27 November 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessValidation of a medically certified, wrist-worn sensor for the assessment of heart rate and energy expenditure during daily activities in patients with chronic heart failure, coronary artery disease and recreational athletes (Preprint)
BACKGROUND Exercise capacity and lifestyle have proven to be important prognostic factors for cardiovascular patients. Both can be ameliorated through different preventive interventions. Cardiac rehabilitation (CR) and remote patient monitoring (RPM) have proven to reduce cardiac events and cardiovascular mortality. One of the most important goals of CR and RPM is improving physical fitness and monitoring of cardiovascular parameters which could predict cardiac deterioration. In order to monitor cardiac patients successfully, reliable and non-obtrusive devices to assess physical activity (PA) and cardiovascular parameters need to be available. OBJECTIVE The aim of this validation study was to determine the accuracy of the Philips health band (PHB), a non-invasive, wrist-worn, medically certified device, for the assessment of heart rate (HR) and energy expenditure (EE) in chronic cardiovascular patients and recreational athletes. METHODS Assessment of HR and EE by the PHB was compared with indirect calorimetry (Oxycon Mobile (OM)) during an activity protocol, consisting of daily activities. Three groups were assessed: patients with heart failure with reduced ejection fraction (HFrEF), patients with stable coronary artery disease (CAD) with preserved left ventricular ejection fraction (LVEF) and recreational athletes (RA). RESULTS A total of 57 patients were included: 19 with CAD, 19 with HFrEF and 19 recreational athletes. HR assessment in the HFrEF and CAD group was significantly underestimated over the entire protocol by the PHB as compared to the OM, with poor and fair reliability respectively. No significant difference in HR was found between the PHB and OM over the entire protocol for the RA group, with a good reliability (HFrEF: mean difference 2.97, p<0.001, ICC 0.36; CAD: mean difference 2.65, p<0.001, ICC 0.55; RA: mean difference 0.78, ICC 0.60). Assessment of EE showed an underestimation over the entire protocol for the RA and CAD group, with poor and fair reliability respectively. The HFrEF group showed no significant difference in EE assessment over the entire protocol, with a poor reliability. (HFrEF: mean difference 0.09, ICC 0.32; CAD: mean difference 0.29, p<0.001, ICC 0.46; RA: mean difference 0.79, p<0.001, ICC 0.26). The responsiveness, to detect within patient changes in activity intensity, of the PHB was moderate for the HFrEF and CAD group, and acceptable for the RA group. CONCLUSIONS HR and EE assessment of a medically certified non-invasive sensor, using PPG and accelerometer, showed poor accuracy and moderate responsiveness during an activity protocol reflecting daily living activities in patients with stable CAD and chronic HFrEF. Accuracy of HR in recreational athletes was good and responsiveness for both HR and EE acceptable. This research confirms prior research and stresses the need for better patient specific algorithms in non-invasive sensors, taking cardiovascular pathology and medication usage into account, for assessing HR and EE, before implementing them in patient care.
- Open Access
- 30 November 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e49346
The Utility of a Novel Electrocardiogram Patch Using Dry Electrodes Technology for Arrhythmia Detection During Exercise and Prolonged Monitoring: Proof-of-Concept Study
Background: Accurate detection of myocardial ischemia and arrhythmias during free-living exercise could play a pivotal role in screening and monitoring for the prevention of exercise-related cardiovascular events in high-risk populations. Although remote electrocardiogram (ECG) solutions are emerging rapidly, existing technology is neither designed nor validated for continuous use during vigorous exercise. Objective: In this proof-of-concept study, we evaluated the usability, signal quality, and accuracy for arrhythmia detection of a single-lead ECG patch platform featuring self-adhesive dry electrode technology in individuals with chronic coronary syndrome. This sensor was evaluated during exercise and for prolonged, continuous monitoring. Methods: We recruited a total of 6 consecutive patients with chronic coronary syndrome scheduled for an exercise stress test (EST) as part of routine cardiac follow-up. Traditional 12-lead ECG recording was combined with monitoring with the ECG patch. Following the EST, the participants continuously wore the sensor for 5 days. Intraclass correlation coefficients (ICC) and Wilcoxon signed rank tests were used to assess the utility of detecting arrhythmias with the patch by comparing the evaluations of 2 blinded assessors. Signal quality during EST and prolonged monitoring was evaluated by using a signal quality indicator. Additionally, connection time was calculated for prolonged ECG monitoring. The comfort and usability of the patch were evaluated by a web-based self-assessment questionnaire. Results: A total of 6 male patients with chronic coronary syndrome (mean age 69.8, SD 6.2 years) completed the study protocol. The patch was worn for a mean of 118.3 (SD 5.6) hours. The level of agreement between the patch and 12-lead ECG was excellent for the detection of premature atrial contractions and premature ventricular contractions during the whole test (ICC=0.998, ICC=1.000). No significant differences in the total number of premature atrial contractions and premature ventricular contractions were detected neither during the entire exercise test (P=.79 and P=.18, respectively) nor during the exercise and recovery stages separately (P=.41, P=.66, P=.18, and P=.66). A total of 1 episode of atrial fibrillation was detected by both methods. Total connection time during recording was between 88% and 100% for all participants. There were no reports of skin irritation, erythema, or pain while wearing the patch. Conclusions: This proof-of-concept study showed that this innovative ECG patch based on self-adhesive dry electrode technology can potentially be used for arrhythmia detection during vigorous exercise. The results suggest that the wearable patch is also usable for prolonged continuous ECG monitoring in free-living conditions and can therefore be of potential use in cardiac rehabilitation and tele-monitoring for the prevention of exercise-related cardiovascular events. Future efforts will focus on optimizing signal quality over time and conducting a larger-scale validation study focusing on both arrhythmia and ischemia detection.
- 30 November 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e49346
Open AccessThe Utility of a Novel Electrocardiogram Patch Using Dry Electrodes Technology for Arrhythmia Detection During Exercise and Prolonged Monitoring: Proof-of-Concept Study
Background: Accurate detection of myocardial ischemia and arrhythmias during free-living exercise could play a pivotal role in screening and monitoring for the prevention of exercise-related cardiovascular events in high-risk populations. Although remote electrocardiogram (ECG) solutions are emerging rapidly, existing technology is neither designed nor validated for continuous use during vigorous exercise. Objective: In this proof-of-concept study, we evaluated the usability, signal quality, and accuracy for arrhythmia detection of a single-lead ECG patch platform featuring self-adhesive dry electrode technology in individuals with chronic coronary syndrome. This sensor was evaluated during exercise and for prolonged, continuous monitoring. Methods: We recruited a total of 6 consecutive patients with chronic coronary syndrome scheduled for an exercise stress test (EST) as part of routine cardiac follow-up. Traditional 12-lead ECG recording was combined with monitoring with the ECG patch. Following the EST, the participants continuously wore the sensor for 5 days. Intraclass correlation coefficients (ICC) and Wilcoxon signed rank tests were used to assess the utility of detecting arrhythmias with the patch by comparing the evaluations of 2 blinded assessors. Signal quality during EST and prolonged monitoring was evaluated by using a signal quality indicator. Additionally, connection time was calculated for prolonged ECG monitoring. The comfort and usability of the patch were evaluated by a web-based self-assessment questionnaire. Results: A total of 6 male patients with chronic coronary syndrome (mean age 69.8, SD 6.2 years) completed the study protocol. The patch was worn for a mean of 118.3 (SD 5.6) hours. The level of agreement between the patch and 12-lead ECG was excellent for the detection of premature atrial contractions and premature ventricular contractions during the whole test (ICC=0.998, ICC=1.000). No significant differences in the total number of premature atrial contractions and premature ventricular contractions were detected neither during the entire exercise test (P=.79 and P=.18, respectively) nor during the exercise and recovery stages separately (P=.41, P=.66, P=.18, and P=.66). A total of 1 episode of atrial fibrillation was detected by both methods. Total connection time during recording was between 88% and 100% for all participants. There were no reports of skin irritation, erythema, or pain while wearing the patch. Conclusions: This proof-of-concept study showed that this innovative ECG patch based on self-adhesive dry electrode technology can potentially be used for arrhythmia detection during vigorous exercise. The results suggest that the wearable patch is also usable for prolonged continuous ECG monitoring in free-living conditions and can therefore be of potential use in cardiac rehabilitation and tele-monitoring for the prevention of exercise-related cardiovascular events. Future efforts will focus on optimizing signal quality over time and conducting a larger-scale validation study focusing on both arrhythmia and ischemia detection.
- Open Access
- 25 May 2023
- Published by JMIR Publications Inc. in JMIR Preprints
The Utility of a Novel Electrocardiogram Patch Using Dry Electrodes Technology for Arrhythmia Detection During Exercise and Prolonged Monitoring: Proof-of-Concept Study (Preprint)
BACKGROUND Accurate detection of myocardial ischemia and arrhythmias during free-living exercise could play a pivotal role in screening and monitoring for the prevention of exercise-related cardiovascular events in high-risk populations. Although remote electrocardiogram (ECG) solutions are emerging rapidly, existing technology is neither designed nor validated for continuous use during vigorous exercise. OBJECTIVE In this proof-of-concept study, we evaluated the usability, signal quality, and accuracy for arrhythmia detection of a single-lead ECG patch platform featuring self-adhesive dry electrode technology in individuals with chronic coronary syndrome. This sensor was evaluated during exercise and for prolonged, continuous monitoring. METHODS We recruited a total of 6 consecutive patients with chronic coronary syndrome scheduled for an exercise stress test (EST) as part of routine cardiac follow-up. Traditional 12-lead ECG recording was combined with monitoring with the ECG patch. Following the EST, the participants continuously wore the sensor for 5 days. Intraclass correlation coefficients (ICC) and Wilcoxon signed rank tests were used to assess the utility of detecting arrhythmias with the patch by comparing the evaluations of 2 blinded assessors. Signal quality during EST and prolonged monitoring was evaluated by using a signal quality indicator. Additionally, connection time was calculated for prolonged ECG monitoring. The comfort and usability of the patch were evaluated by a web-based self-assessment questionnaire. RESULTS A total of 6 male patients with chronic coronary syndrome (mean age 69.8, SD 6.2 years) completed the study protocol. The patch was worn for a mean of 118.3 (SD 5.6) hours. The level of agreement between the patch and 12-lead ECG was excellent for the detection of premature atrial contractions and premature ventricular contractions during the whole test (ICC=0.998, ICC=1.000). No significant differences in the total number of premature atrial contractions and premature ventricular contractions were detected neither during the entire exercise test (P=.79 and P=.18, respectively) nor during the exercise and recovery stages separately (P=.41, P=.66, P=.18, and P=.66). A total of 1 episode of atrial fibrillation was detected by both methods. Total connection time during recording was between 88% and 100% for all participants. There were no reports of skin irritation, erythema, or pain while wearing the patch. CONCLUSIONS This proof-of-concept study showed that this innovative ECG patch based on self-adhesive dry electrode technology can potentially be used for arrhythmia detection during vigorous exercise. The results suggest that the wearable patch is also usable for prolonged continuous ECG monitoring in free-living conditions and can therefore be of potential use in cardiac rehabilitation and tele-monitoring for the prevention of exercise-related cardiovascular events. Future efforts will focus on optimizing signal quality over time and conducting a larger-scale validation study focusing on both arrhythmia and ischemia detection.
- 25 May 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Utility of a Novel Electrocardiogram Patch Using Dry Electrodes Technology for Arrhythmia Detection During Exercise and Prolonged Monitoring: Proof-of-Concept Study (Preprint)
BACKGROUND Accurate detection of myocardial ischemia and arrhythmias during free-living exercise could play a pivotal role in screening and monitoring for the prevention of exercise-related cardiovascular events in high-risk populations. Although remote electrocardiogram (ECG) solutions are emerging rapidly, existing technology is neither designed nor validated for continuous use during vigorous exercise. OBJECTIVE In this proof-of-concept study, we evaluated the usability, signal quality, and accuracy for arrhythmia detection of a single-lead ECG patch platform featuring self-adhesive dry electrode technology in individuals with chronic coronary syndrome. This sensor was evaluated during exercise and for prolonged, continuous monitoring. METHODS We recruited a total of 6 consecutive patients with chronic coronary syndrome scheduled for an exercise stress test (EST) as part of routine cardiac follow-up. Traditional 12-lead ECG recording was combined with monitoring with the ECG patch. Following the EST, the participants continuously wore the sensor for 5 days. Intraclass correlation coefficients (ICC) and Wilcoxon signed rank tests were used to assess the utility of detecting arrhythmias with the patch by comparing the evaluations of 2 blinded assessors. Signal quality during EST and prolonged monitoring was evaluated by using a signal quality indicator. Additionally, connection time was calculated for prolonged ECG monitoring. The comfort and usability of the patch were evaluated by a web-based self-assessment questionnaire. RESULTS A total of 6 male patients with chronic coronary syndrome (mean age 69.8, SD 6.2 years) completed the study protocol. The patch was worn for a mean of 118.3 (SD 5.6) hours. The level of agreement between the patch and 12-lead ECG was excellent for the detection of premature atrial contractions and premature ventricular contractions during the whole test (ICC=0.998, ICC=1.000). No significant differences in the total number of premature atrial contractions and premature ventricular contractions were detected neither during the entire exercise test (P=.79 and P=.18, respectively) nor during the exercise and recovery stages separately (P=.41, P=.66, P=.18, and P=.66). A total of 1 episode of atrial fibrillation was detected by both methods. Total connection time during recording was between 88% and 100% for all participants. There were no reports of skin irritation, erythema, or pain while wearing the patch. CONCLUSIONS This proof-of-concept study showed that this innovative ECG patch based on self-adhesive dry electrode technology can potentially be used for arrhythmia detection during vigorous exercise. The results suggest that the wearable patch is also usable for prolonged continuous ECG monitoring in free-living conditions and can therefore be of potential use in cardiac rehabilitation and tele-monitoring for the prevention of exercise-related cardiovascular events. Future efforts will focus on optimizing signal quality over time and conducting a larger-scale validation study focusing on both arrhythmia and ischemia detection.
- Open Access
- 28 July 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (8) , ytac309
Exercise-related major adverse cardiovascular events in asymptomatic recreational master athletes: a case series
Background: In master athletes, atherosclerotic coronary artery disease (CAD) is the primary condition leading to major adverse cardiovascular events during sports. We report two cases of asymptomatic recreational athletes who suffered from an exercise-induced cardiovascular event. Case summary: The first athlete is a 70-year-old male speed skater without known history of cardiovascular disease. He has no typical risk factors for CAD and denied preceding symptoms. During training at the speed skating rink, he suddenly experienced severe chest pain. Electrocardiogram (ECG) showed ST-segment elevation in the precordial leads. In the ambulance, an episode of ventricular fibrillation was converted to atrial fibrillation. Coronary angiography showed a thrombus in the left anterior descending (LAD) coronary artery, treated with a glycoprotein IIb/IIIa inhibitor intravenously. The second athlete is a 59-year-old male endurance athlete who presented with chest pain during cycling. He had a history of cavotricuspid isthmus ablation and pulmonary vein isolation for paroxysmal atrial fibrillation and flutter but experienced no symptoms in the weeks prior to the event. He also had no risk factors for CAD. ECG showed ST-segment elevation in the inferior leads and reciprocal depression in V2–V4. Successful primary percutaneous intervention of the circumflex artery was performed. Discussion: Limited data are available to guide recommendations for cardiovascular screening in master athletes. Since master athletes with CAD are often asymptomatic, more knowledge on the optimal pre-participation screening algorithm for identifying individuals at risk of adverse cardiac events is required.
- 28 July 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (8) , ytac309
Open AccessExercise-related major adverse cardiovascular events in asymptomatic recreational master athletes: a case series
Background: In master athletes, atherosclerotic coronary artery disease (CAD) is the primary condition leading to major adverse cardiovascular events during sports. We report two cases of asymptomatic recreational athletes who suffered from an exercise-induced cardiovascular event. Case summary: The first athlete is a 70-year-old male speed skater without known history of cardiovascular disease. He has no typical risk factors for CAD and denied preceding symptoms. During training at the speed skating rink, he suddenly experienced severe chest pain. Electrocardiogram (ECG) showed ST-segment elevation in the precordial leads. In the ambulance, an episode of ventricular fibrillation was converted to atrial fibrillation. Coronary angiography showed a thrombus in the left anterior descending (LAD) coronary artery, treated with a glycoprotein IIb/IIIa inhibitor intravenously. The second athlete is a 59-year-old male endurance athlete who presented with chest pain during cycling. He had a history of cavotricuspid isthmus ablation and pulmonary vein isolation for paroxysmal atrial fibrillation and flutter but experienced no symptoms in the weeks prior to the event. He also had no risk factors for CAD. ECG showed ST-segment elevation in the inferior leads and reciprocal depression in V2–V4. Successful primary percutaneous intervention of the circumflex artery was performed. Discussion: Limited data are available to guide recommendations for cardiovascular screening in master athletes. Since master athletes with CAD are often asymptomatic, more knowledge on the optimal pre-participation screening algorithm for identifying individuals at risk of adverse cardiac events is required.